There was shown the prevalence of vascular diseases, including acute cerebrovascular events, reasons of such disorders being multiple systemic changes of neuron metabolism. The correction of imbalance of excitatory and inhibitory neurotransmitter systems is one of the most promising methods of neuroprotection. Much attention is paid to the role of an inhibitory neurotransmitter glycine in the mechanisms of acute cerebral ischemia. Positive effects of glycine on neuronal mitochondrial metabolism have been observed under hypoxic (anoxic) conditions. It was also shown a reduction of events which had been induced by glutamate concentration excess. Along with the effect of direct vasodilation of glycine on arterioles of different tissues it enables to consider glycine as a neuroprotective compound i.e. the medicines which protect against ischemic cascade in therapeutic window.

About the authors

Yaroslav R Nartsissov

Institute of Cytochemistry and Molecular Pharmacology

115404, Moscow, 6th Radialnaya str., 24/14

Elena V Sheshegova

Institute of Cytochemistry and Molecular Pharmacology

115404, Moscow, 6th Radialnaya str., 24/14

Elena V Mashkovtseva

Institute of Cytochemistry and Molecular Pharmacology

115404, Moscow, 6th Radialnaya str., 24/14

Lyudmila N Maksimova

Institute of Cytochemistry and Molecular Pharmacology

115404, Moscow, 6th Radialnaya str., 24/14


  1. Гусев Е.И. Скворцова В.И. Метаболическая защита головного мозга в остром периоде ишемического инсульта / II Российский Национальный конгресс «Человек и лекарство». М., 1995. С. 220
  2. Гусев Е.И., Cкворцова В.И., Раевский К.С. и др. Влияние глицина на содержание нейротрансмиттерных аминокислот в спинномозговой жидкости у больных в остром периоде ишемического инсульта. В кн.: Достижения клинической фармакологии. М., 1999. С. 41-42
  3. Гусев Е.И., Скворцова В.И. Ишемия головного мозга. М: Медицина, 2001
  4. Дъячкова Н.Г., Гудкова Ю.В., Солдатенкова Т.Д. и др. Применение препарата Глицин для профилактики ишемического инсульта / III Российский Национальный конгресс «Человек и лекарство». М., 1996. С. 112
  5. Комиссарова И.А., Гудкова Ю.В. и др. Патент РФ № 2025124, 1992
  6. Лаптева Н.Л., Визило Т.Л., Трубицына М.В. и др. Степень выраженности когнитивных нарушений и изменение вегетативной нервной системы у пациентов в отдаленном периоде ишемического инсульта // Журнал неврологии и психиатрии. 2014. Т. 114, №8. С. 140
  7. Липская Л.А. Цитология. 1994. Т. 36(3). С. 303-309
  8. Скворцова В.И., Евзельман М.А. Ишемический инсульт. Орел, 2006. 404 с
  9. Скворцова В.И. Клинический и нейрофизиологический мониторинг, метаболическая терапия в остром периоде ишемического инсульта: Автореф. докт. мед. наук. М., 1993
  10. Скворцова В.И., Раевский К.С, Коваленко А.В. и др. Нейропротективное действие глицина в остром периоде ишемического инсульта // Журн. неврол. и психиатр. 1999. Т. 99, № 2. С. 34-39
  11. Appelros P., Jonsson F., Asplund K. et al. Trends in baseline patient characteristics during the years 1995-2008: observations from Riks-Stroke, the Swedish Stroke Register // Cerebrovascular Dis. 2010. Vol. 30 (2). P. 114-119
  12. Ashman A.A. Poverenova O.V. Principles of the therapy of a brain stroke. Samara, 2011. P. 65-66
  13. Bennett M.R., Huxlin K.R. Neuronal cell death in the mammalian nervous system: the calmortin hypothesis // Gen Pharmacol. 1996. Vol. 27. P. 407-419
  14. Briones T.L., Suh E., Jozsa, L. Changes in number of synapses and mitochondria in presynaptic terminals in the dentate gyrus following cerebral ischemia and rehabilitation training // Brain Research. 2005. Vol. 1033(1). P. 51-57
  15. Catarzi D., Colotta V., Varano F. Competitive Gly/NMDA receptor antagonists // Current topics in medicinal chemistry. 2006. Vol. 6(8). P. 809-821
  16. Choi D.W. Cerebral hypoxia: some new approaches and unanswered questions // J. Neurosci. 1990. Vol. 10. P. 2493-2501
  17. Easton D. AHА/ ASA Scientific Statement Definition and Evaluation of Transient Ischemic Attack // Stroke. 2009. Vol. 40. P. 2276-2293
  18. Fox P.T., Raichle M.E., Mintun M.A., Dence C. Nonoxidative glucose consumption during focal physiologic neural activity // Science. 1988. Vol. 241. P. 462-464
  19. Frahm J., Krüger G., Merboldt K.D., Kleinschmidt A. Dynamic uncoupling and recoupling of perfusion and oxidative metabolism during focal brain activation in man // Magnetic Resonance in Medicine. 1996. Vol. 35(2). P. 143-148
  20. Globus M.Y., Busto R., Martinez E. Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat // J. Neurochem. 1991. Vol. 57. P. 470-478
  21. Gusev E.I., Skvortsova V.I., Dambinova S.A. et al. Neuroprotective effects of glycine for therapy of acute ischemic stroke // Cerebrovasc Dis. 2000 Jan-feb. Vol. 10(1). P. 49-60
  22. Haddad G.G., Jiang C. O2 deprivation in the central nervous system: on mechanisms of neuronal response, differential sensitivity and injury // Prog. Neurobiol. 1993. Vol. 40. P. 277-318
  23. Hegstad E., Berg-Johnsen J., Haugstad T.S. et al. Amino-acid release from human cerebral cortex during simulated ischaemia in vitro // Acta neurochir (Wien). 1996. Vol. 138(2). P. 234-241
  24. Hossman K.A. Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised // Brain Pathol. 1994. Vol. 4. P. 23-36
  25. Leng T., Shi Y., Xiong Z.G., Sun D. Proton-sensitive cation channels and ion exchangers in ischemic brain injury: new therapeutic targets for stroke? // Progress in neurobiology. 2014. Vol. 115. P. 189-209
  26. Lobysheva N.V., Tonshin A.A., Selin A.A. Diversity of neurodegenerative processes in the model of brain cortex tissue ischemia // Neurochemistry International. 2009. Vol. 54 (5-6). P. 322-329
  27. Ly C.V., Verstreken P. Mitochondria at the synapse // Neuroscientist. 2006. Vol. 12(4). P. 291-299
  28. Oda M., Kure S., Sugawara T. et al. Direct correlation between ischemic injury and extracellular glycine concentration in mice with genetically altered activities of the glycine cleavage multienzyme system // Stroke. 2007. Vol. 38(7). P. 2157-2164
  29. Olney J.W. New mechanisms of excitatory transmitter neurotoxicity // J. Neural. Transm Suppl. 1994. Vol. 43. P. 47-51
  30. Orrenius S., McCabe M.S., Nicotera P. Ca(2+)-dependent mechanisms of cytotoxicity and programmed cell death // Toxicol Lett. 1992. Vol. 64-65 Spec No. P. 357-364
  31. Podoprigora G.I., Nartsissov Y.R., Aleksandrov P.N. Effect of glycine on microcirculation in pial vessels of rat brain // Bull. Exp. Biol. Med. 2005. Vol. 139. P. 675-677
  32. Scheinberg P. The biologic basis for the treatment of acute stroke // Neurology. 1991. Vol. 41. P. 1867-1873
  33. Selin A.A., Lobysheva N.V., Vorontsova O.N. Mechanism underlying the protective effect of glycine in energetic disturbances in brain tissues under hypoxic conditions // Bulletin of Experimental Biology and Medicine. 2012. Vol. 153 (1). P. 44-47
  34. Siesjo B.K. Calcium and ischemic brain damage // Eur. Neurol. 1986. Vol. 25 (1). P. 45-56
  35. Skulachev V.P. Bioenergetic aspects of apoptosis, necrosis and mitoptosis // Apoptosis. 2006. Vol. 11 (4). P. 473-485
  36. Skvortsova V.I., Nartsissov Y.R., Bodykhov M.K. et al. Oxidative stress and oxygen status in ischemic stroke // Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2007. Vol. 107(1). P. 30-36
  37. Terasaki Y., Liu Y., Hayakawa K. et al. Mechanisms of neurovascular dysfunction in acute ischemic brain // Current Medicinal Chemistry. 2014. Vol. 21 (18). P. 2035-2042
  38. Tong J.J. Mitochondrial delivery is essential for synaptic potentiation // Biological Bulletin. 2007. Vol. 212(2). P. 169-175
  39. Wallace K.B. Mitochondrial off targets of drug therapy // Trends in Pharmacological Sciences. 2008. Vol. 29(7). P. 361-366
  40. Zhao P., Qian H., XiaY. GABA and glycine are protective to mature but toxic to immature rat cortical neurons under hypoxia // Eur. J. Neurosci. 2005. Vol. 22(2). P. 289-300
  41. Zhong Z., Wheeler M.D., Li X. et al. L-Glycine: a novel anti-inflammatory, immunomodulatory, and cytoprotective agent // Curr. Opin. Clin. Nutr. Metab. Care. 2003. Vol. 6(2). P. 229-240



Abstract - 75

PDF (Russian) - 16





  • There are currently no refbacks.

Copyright (c) 2015 Nartsissov Y.R., Sheshegova E.V., Mashkovtseva E.V., Maksimova L.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies